Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy

被引：0
|
作者：
Deneke, M. G. [1 ]
Dranoff, J. A. [1 ,2 ]
Duarte-Rojo, A. [1 ]
机构：
[1] Univ Arkansas Ciencias Med, Div Gastroenterol & Hepatol, 4301 W Markham 567, Little Rock, AR 72205 USA
[2] Arkansas Cent, Serv Invest, Serv Salud Vet Affairs, Little Rock, AR USA
来源：
REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2014年 / 79卷 / 01期
关键词：
D O I：
10.1016/j.rgmx.2013.09.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：64 / 66
页数：4
相关论文
共 50 条
  • [21] Weight Loss during Telaprevir-based Triple Therapy due to Telaprevir-induced Appetite Loss
    Nomura, Hideyuki
    Miyagi, Yuugou
    Tanimoto, Hironori
    Kawano, Akira
    Yamashita, Nobuyuki
    INTERNAL MEDICINE, 2014, 53 (22) : 2567 - 2573
  • [22] Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C
    Al-Bawardy, Badr
    Kim, W. Ray
    Poterucha, John J.
    Gross, John B.
    Charlton, Michael R.
    Larson, Joseph J.
    Colby, Colin L.
    Canterbury, Kathy
    Warner, Jennifer
    Therneau, Terry M.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (05) : 595 - 601
  • [23] Telaprevir-based and simeprevir-based interferon triple therapy for patients with hepatitis C
    Sasaki, Masato
    Tanaka, Hideki
    Takeguchi, Masataka
    Mochinaga, Takaho
    Matsushita, Hiroshi
    Kurano, Soutaro
    Nakamura, Aiko
    Yoshida, Kenichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 382 - 382
  • [24] Postmarketing surveillance of telaprevir-based triple therapy for chronic hepatitis C in Japan
    Shiraishi, Muneshige
    Umebayashi, Itsuro
    Matsuda, Hiroaki
    Sawamura, Keisuke
    Okada, Aiko
    Karino, Masako
    Nogami, Yoshihide
    HEPATOLOGY RESEARCH, 2015, 45 (13) : 1267 - 1275
  • [25] Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C
    Senates, Ebubekir
    Colak, Yasar
    Yesil, Atakan
    Tuncer, Ilyas
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (03): : 283 - 283
  • [26] Response to peginterferon plus ribavirin and subsequent retreatment with telaprevir-based triple therapy in a patient with chronic lymphocytic leukaemia and chronic HCV genotype 1b infection
    Stefan Christensen
    Anton Gillessen
    Infectious Agents and Cancer, 9
  • [27] Response to peginterferon plus ribavirin and subsequent retreatment with telaprevir-based triple therapy in a patient with chronic lymphocytic leukaemia and chronic HCV genotype 1b infection
    Christensen, Stefan
    Gillessen, Anton
    INFECTIOUS AGENTS AND CANCER, 2014, 9
  • [28] Reduced-Dose Telaprevir-Based Triple Antiviral Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation
    Ikegami, Toru
    Yoshizumi, Tomoharu
    Kato, Masaki
    Yamamoto, Satomi
    Fukuhara, Takasuke
    Matsuura, Yoshiharu
    Nakamura, Shota
    Itoh, Shinji
    Shirabe, Ken
    Maehara, Yoshihiko
    TRANSPLANTATION, 2014, 98 (09) : 994 - 999
  • [29] SAFETY AND TOLERABILITY OF TELAPREVIR-BASED TRIPLE THERAPY IN HIV/HCV COINFECTED VERSUS HCV MONOINFECTED PATIENTS IN "REAL LIFE": A MATCHED-COHORT STUDY
    Pascale, A.
    Boyd, A.
    Bottero, J.
    Stitou, H.
    Valin, N.
    Benjelloun, F.
    Chazouilleres, O.
    Girard, P. -M.
    Serfaty, L.
    Lacombe, K.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S365 - S366
  • [30] The Safety Profile of Telaprevir-Based Triple Therapy in Clinical Practice: A Retrospective Cohort Study
    Iketani, Ryo
    Ide, Kazuki
    Yamada, Hiroshi
    Kawasaki, Yohei
    Masaki, Naohiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (05) : 687 - 692
12345